Navigation Links
NABP Stresses Need for International Collaboration to Combat Online Counterfeit Drug Distribution
Date:7/20/2012

MOUNT PROSPECT, Ill., July 20, 2012 /PRNewswire-USNewswire/ -- The National Association of Boards of Pharmacy® (NABP®) today issued a report about the continually increasing online counterfeit drug supply and the urgent need for international collaboration among regulators and other public agencies as well as private sector entities. As described in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2012, counterfeit drugs sold online often make their way to unwary consumers through a complex chain of international transactions by multiple parties, and international, public-private collaborative efforts are needed to combat this illegal activity.

NABP continues to review and monitor Web sites selling prescription drugs and its findings are also presented in the report released today – of more than 10,000 Web sites analyzed, 97% operate out of compliance with pharmacy laws and practice standards established in the United States, and many other developed countries, to protect public health. Such sites provide an outlet for counterfeit medicines to enter the US drug supply, endangering the health and safety of Americans.

The report provides an overview of collaborative strategies from pharmacy experts to stop online counterfeit drug distribution. Public and private sector experts on international health law and global pharmaceutical security assert that rogue online drug sellers work with a network of private sector entities – some legitimate and some rogue – to obtain, market, collect payment for, and distribute drug products that are often counterfeit or substandard. Experts call for public-private partnerships to promote the adoption of effective laws, regulations, and policies addressing all levels of this complex chain, along with effective enforcement efforts. Additionally, consumer education about rogue online drug sites and counterfeit drug dangers is necessary.

NABP is committed to fostering opportunities for international collaboration, and, with the support of the global pharmacy community, NABP has applied for the .pharmacy generic Top-Level Domain which would offer consumers around the globe a trusted means for obtaining the safest medications online. As Internet commerce becomes increasingly commonplace, NABP President Michael A. Burleson, RPh, also expressed the need to raise awareness about counterfeit medicine and rogue online sellers, giving special emphasis to recent endeavors including international pharmacy initiatives and the AWARxE® Consumer Protection Program. President Burleson stated, "Focusing on the topics of safe drug disposal, online pharmacies, and counterfeit drug dangers, AWARxE educates consumers on prescription drug safety."

As indicated in the report released today, NABP has reviewed more than 10,000 Web sites and the vast majority of sites (97%) were found to be operating out of compliance with US pharmacy laws and are listed as Not Recommended on NABP's consumer protection Web site, www.AWARErx.org. The 9,734 Internet drug outlets currently listed as Not Recommended are characterized as follows:

  • 9,261 appear to be affiliated with a network that obtains drugs from questionable sources
  • 4,828 offer foreign or non-Food and Drug Administration-approved drugs
  • 8,497 do not require a valid prescription
  • 2,271 have a physical address located outside of the US (most rogue sites post no address whatsoever)
  • 3,614 have server locations in foreign countries

To help consumers find the safest sources for purchasing medicine online, NABP developed the VIPPS® (Verified Internet Pharmacy Practice Sites) accreditation program. Consumers should look for the VIPPS Seal on an accredited site, or check NABP's database on its consumer protection Web site, www.AWARErx.org. As part of its continued efforts to combat these rogue sites, NABP and the state boards of pharmacy are stepping up their efforts to educate the public through the AWARxE consumer protection program. The AWARxE Web site provides information on safely obtaining medications and includes updated news, tips, information, and links to relevant NABP resources.

For the full report with detailed findings on the characteristics of rogue Web sites, visit www.AWARErx.org/Not_Recommended_Sites.php.

NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.



'/>"/>
SOURCE National Association of Boards of Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
2. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. International Drug & Explosives Detection Company Identa Corp to Dispatch First Order to Drug Store Chain
4. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
5. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
6. Remedy Informatics Joins LongView International Technology Solutions Team to Win CIO-SP3 Contract Award
7. Vomaris patent estate grows to six issued U.S. patents and three granted international patents with U.S. Pat. No. 8,224,439
8. Intellipharmaceutics International Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
9. DATATRAK International, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
10. Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress
11. Bacterin International Signs Its Fourth National GPO Contract with the Premier healthcare alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):